{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:14:31Z","timestamp":1772586871458,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.2146\/ajhp130700","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T16:19:33Z","timestamp":1405441173000},"page":"1288-1291","source":"Crossref","is-referenced-by-count":4,"title":["Visual compatibility of defibrotide with selected drugs during simulated Y-site administration"],"prefix":"10.1093","volume":"71","author":[{"given":"Florian","family":"Correard","sequence":"first","affiliation":[{"name":"Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France. Pascale Pisano, Pharm.D., Ph.D., is Pharmacist, Pharmacology Laboratory and Faculty of Pharmacy, Aix Marseille University, Marseille. Bertrand Pourroy, Pharm.D., Ph.D., is Pharmacist, Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Savry","sequence":"additional","affiliation":[{"name":"Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France. Pascale Pisano, Pharm.D., Ph.D., is Pharmacist, Pharmacology Laboratory and Faculty of Pharmacy, Aix Marseille University, Marseille. Bertrand Pourroy, Pharm.D., Ph.D., is Pharmacist, Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Gauthier-Villano","sequence":"additional","affiliation":[{"name":"Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France. Pascale Pisano, Pharm.D., Ph.D., is Pharmacist, Pharmacology Laboratory and Faculty of Pharmacy, Aix Marseille University, Marseille. Bertrand Pourroy, Pharm.D., Ph.D., is Pharmacist, Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Pisano","sequence":"additional","affiliation":[{"name":"Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France. Pascale Pisano, Pharm.D., Ph.D., is Pharmacist, Pharmacology Laboratory and Faculty of Pharmacy, Aix Marseille University, Marseille. Bertrand Pourroy, Pharm.D., Ph.D., is Pharmacist, Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Pourroy","sequence":"additional","affiliation":[{"name":"Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital, Marseille, France. Pascale Pisano, Pharm.D., Ph.D., is Pharmacist, Pharmacology Laboratory and Faculty of Pharmacy, Aix Marseille University, Marseille. Bertrand Pourroy, Pharm.D., Ph.D., is Pharmacist, Oncopharma Unit, Pharmacy Department, La Timone University Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041211095063300_b1-0711288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","article-title":"Defibrotide: properties and clinical use of an old\/new drug","volume":"59","author":"Pescador","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"2019041211095063300_b2-0711288","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"2019041211095063300_b3-0711288","unstructured":"Committee for Medicinal Products for Human Use, European Medicines Agency. Summary of positive opinion for Defitelio. www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-Initial_authorisation\/human\/002393\/WC500146653.pdf (accessed 2013 Jul 25)."},{"key":"2019041211095063300_b4-0711288","unstructured":"ClinicalTrials.gov. Defibrotide for patients with hepatic veno-occlusive disease: a treatment IND study (updated January 13, 2014). http:\/\/clinicaltrials.gov\/show\/NCT00628498 (accessed 2014 May 2)."},{"key":"2019041211095063300_b5-0711288","unstructured":"European Medicines Agency. Defitelio public assessment report. www.ema.europa.eu\/docs\/en_GB\/document_library\/Summary_of_opinion_-_initial_authorisation\/human\/002393\/WC500146653.pdf (accessed 2013 Jul 25)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/15\/1288\/28373077\/ajhp1288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T20:51:56Z","timestamp":1555102316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/15\/1288\/5110965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":5,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130700","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8,1]]},"published":{"date-parts":[[2014,8,1]]}}}